Missouri Trust & Investment Co Purchases Shares of 36,910 Bath & Body Works, Inc. (NYSE:BBWI)

Missouri Trust & Investment Co acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 36,910 shares of the company’s stock, valued at approximately $1,178,000.

Other hedge funds have also recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. boosted its stake in Bath & Body Works by 5.2% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 5,571 shares of the company’s stock valued at $279,000 after purchasing an additional 277 shares during the last quarter. CWM LLC grew its holdings in Bath & Body Works by 6.6% during the second quarter. CWM LLC now owns 5,072 shares of the company’s stock worth $198,000 after buying an additional 314 shares in the last quarter. Northwest Bank & Trust Co raised its position in Bath & Body Works by 2.5% in the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after buying an additional 315 shares during the last quarter. DekaBank Deutsche Girozentrale lifted its stake in Bath & Body Works by 1.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after acquiring an additional 322 shares in the last quarter. Finally, Citizens & Northern Corp boosted its holdings in Bath & Body Works by 1.7% during the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock worth $1,151,000 after acquiring an additional 487 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Price Performance

Shares of BBWI traded down $0.11 during midday trading on Tuesday, hitting $31.40. 485,918 shares of the company traded hands, compared to its average volume of 3,816,093. The stock has a 50-day moving average of $30.02 and a 200-day moving average of $36.77. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99. The firm has a market cap of $6.88 billion, a P/E ratio of 7.63, a PEG ratio of 0.95 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Sell-side analysts forecast that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.55%. Bath & Body Works’s payout ratio is 19.37%.

Analyst Ratings Changes

Several equities analysts have commented on the stock. UBS Group dropped their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. Barclays cut Bath & Body Works from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $31.00 to $28.00 in a research report on Friday. Evercore ISI decreased their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research report on Wednesday, August 28th. JPMorgan Chase & Co. cut their price target on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. Finally, Bank of America decreased their price target on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $42.44.

Insider Buying and Selling

In related news, CEO Gina Boswell acquired 6,000 shares of Bath & Body Works stock in a transaction on Wednesday, October 9th. The shares were acquired at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is owned by insiders.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.